NCT07023536 (TELEREHAB-HF) is a clinical trial of TELEREHABILITATION-YES in Heart Failure, sponsored by University of Salerno.

Who is sponsoring NCT07023536?

NCT07023536 is sponsored by University of Salerno.

What drugs are being tested in NCT07023536?

Interventions in NCT07023536: TELEREHABILITATION-YES, TELEREHABILITATION-NO.

What condition does NCT07023536 study?

NCT07023536 studies Heart Failure.

Is NCT07023536 still recruiting?

NCT07023536 is currently recruiting now. Last updated 11 March 2026.

Last reviewed 2026-03-11 · How we verify

NCT07023536: TELEREHAB-HF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure

Recruiting now Last updated 11 March 2026

What this trial tests

trial testing TELEREHABILITATION-YES in Heart Failure in 205 participants. Currently enrolling.

Timeline

10 June 2025

Primary endpoint
1 July 2026

1 December 2026

Quick facts

Lead sponsor	University of Salerno
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	205
Start date	10 June 2025
Primary completion	1 July 2026
Estimated completion	1 December 2026
Sites	1 location across Italy

Drugs / interventions tested

TELEREHABILITATION-YES
TELEREHABILITATION-NO

Conditions studied

Heart Failure — all drugs for Heart Failure →

Sponsor

University of Salerno

Who can join

18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to evaluate whether a home-based cardiac tele-rehabilitation program can improve functional capacity in adults (18 years and older) with chronic heart failure. The main questions it aims to answer are: Does tele-rehabilitation improve peak oxygen uptake (VO₂ max) compared to standard in-hospital rehabilitation? Does it improve cardiac function, exercise tolerance, biochemical markers, and quality of life? Are functional gains maintained at 24 weeks? Researchers will compare patients who opt for tele-rehabilitation using wearable devices and a remote monitoring platform with those undergoing standard in-person rehabilitation. Participants will follow an 8-week individualized training program and undergo assessments at baseline, 4, 8, 16, and 24 weeks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluation of the Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure: Design and Rationale of the TELEREHAB-HF Study.
Garofano M, Vecchione C, Calabrese M, Rusciano MR, et al · · 2025 · PMID 40868691 · DOI 10.3390/healthcare13162074

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other University of Salerno trials

Trials by the same sponsor.

NCT06909682 — AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices · recruiting
NCT06381947 — Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients · Phase 4 · not yet recruiting
NCT06589063 — Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis · recruiting
NCT05854342 — Evaluation of the Effects of Bicarbonate-calcium Water in Premenopausal and Postmenopausal Women as a Prevention of Oste · NA · completed
NCT04655079 — Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) in Progressive Supranuclear Palsy (PSP) (STIM-PSP) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07023536 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Salerno
Last refreshed: 11 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07023536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing